DRKS00009020
Not yet recruiting
未知
Focal therapy of recurrent prostate cancer after external beam radiation therapy using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technology (FOXPRO_RAD) – an initial pilot study - FOXPRO_RAD
Klinik für Urologie, Universitätsmedizin Mannheim0 sites15 target enrollmentOctober 12, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- C61
- Sponsor
- Klinik für Urologie, Universitätsmedizin Mannheim
- Enrollment
- 15
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Previous external beam radiation therapy of prostate cancer \-Serum PSA: PSA \= 10 ng/ml \- mpMRT/TRUS bioptic proven recurrent prostate cancer radiation therapy: \- Clinical stage: localized, unifocal \- Gleason score \= 4 \+ 3 \- Life expectancy \> 10 yr
Exclusion Criteria
- •urinary tract infection; metastases of prostate cancer
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Focal therapy for locally recurrent prostate cancerprostate cancerJPRN-UMIN000038761Tokyo Medical and Dental University100
Completed
Not Applicable
Focal therapy of localized prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technologyC61Malignant neoplasm of prostateDRKS00007105Klinik für Urologie, Universitätsmedizin Mannheim50
Recruiting
Phase 2
Primary focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000050997Saitama Cancer Center200
Unknown
Not Applicable
Follow-up study for localized prostate cancer treated by hormonal therapy or radical prostatectomy.Prostate cancerJPRN-UMIN000000570J-CaP study group2,000
Recruiting
Phase 2
Salvage focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000051113Saitama Cancer Center100